Back to Peptides
RecoveryLow Risk

KPV

Also known as: Lys-Pro-Val, alpha-MSH tripeptide

Half-life:
Short (minutes to hours)

Administration Routes

oralsubcutaneous injectiontopical
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.

Mechanism of Action

Derived from alpha-MSH; binds melanocortin receptors MC1R/MC3R to suppress NF-κB and inflammatory cytokines

A tripeptide fragment of alpha-MSH with potent anti-inflammatory properties. Used for inflammatory bowel conditions and wound healing.

Primary Research Areas

  • anti-inflammatory
  • gut healing
  • wound healing

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Consult a healthcare professional before use.

Regulatory Status

Research OnlyNot Evaluated by FDA

Alpha-MSH C-terminal tripeptide fragment (Lys-Pro-Val). Anti-inflammatory. No FDA approval, no NDA or IND. Not on any FDA list. Research chemical only.

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find KPV